Cargando…
Characteristics of suboptimal immune response after initiating antiretroviral therapy among people living with HIV with a pre-treatment CD4 T cell count <200 cells/mm(3) in Thailand()
BACKGROUND: Complete recovery of the CD4 T cell count is uncommon among chronically HIV-infected individuals with very low pre-treatment CD4 count. We studied the prevalence of chronically immune recovery and its associated factors including immune characteristics chronic HIV-infected Thais. METHODS...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646671/ https://www.ncbi.nlm.nih.gov/pubmed/33251023 http://dx.doi.org/10.1016/j.jve.2020.100005 |
_version_ | 1783606829740195840 |
---|---|
author | Han, Win Min Ubolyam, Sasiwimol Apornpong, Tanakorn Kerr, Stephen J. Hansasuta, Pokrath Gatechompol, Sivaporn Maekanantawat, Wirach Ruxrungtham, Kiat Phanuphak, Praphan Ananworanich, Jintanat Avihingsanon, Anchalee |
author_facet | Han, Win Min Ubolyam, Sasiwimol Apornpong, Tanakorn Kerr, Stephen J. Hansasuta, Pokrath Gatechompol, Sivaporn Maekanantawat, Wirach Ruxrungtham, Kiat Phanuphak, Praphan Ananworanich, Jintanat Avihingsanon, Anchalee |
author_sort | Han, Win Min |
collection | PubMed |
description | BACKGROUND: Complete recovery of the CD4 T cell count is uncommon among chronically HIV-infected individuals with very low pre-treatment CD4 count. We studied the prevalence of chronically immune recovery and its associated factors including immune characteristics chronic HIV-infected Thais. METHODS: Treatment-naïve participants (n = 375) from the HIV-NAT 006 cohort with a pre-treatment CD4 T cell count after initiating antiretroviral therapy (ART) and having achieved a suppressed viremia (HIV-RNA level < 400 copies/mL) were retrospectively followed at the Thai Red Cross AIDS Research Centre, Bangkok, Thailand. Suboptimal immune recovery (SIR) was defined as having a CD4(+) T cell count <200 cells/mm(3) for 3 years after ART initiation. A case-control sub-study matched for age, sex and pre-ART CD4 T cell count was conducted to compare immunological characteristics between SIR (n = 17) and non-SIR (n = 24) participants. Immunological biomarkers such as interleukin-7 (IL-7) and soluble CD14 (sCD14) and other covariates including cytomegalovirus (CMV) DNA level, baseline hemoglobin level, hepatitis B and C co-infections, and T cell subsets associated with immune activation and exhaustion were evaluated. RESULTS: Among 375 participants with pre-ART CD4 T cell counts < 200 cells/mm(3), the prevalence of SIR was 39.7%, 19.7% and 7.7% at years 1, 2 and 3 after starting ART, respectively. In a multivariate analysis, a pre-ART CD4 T cell count ≤100 cells/mm(3) (adjusted odds ratio [aOR] 9.45, 95% CI 2.92–30.61, p < 0.001), older age (aOR 1.07, 95% CI 1.01–1.13, p = 0.029) and baseline HIV-RNA level (aOR 0.36, 95% CI 0.21–0.59, p < 0.001) were independently associated with SIR at year 3 after ART initiation. In the matched case-control sub-study (cases = 17, controls = 24), there was a higher prevalence of hepatitis C co-infection (18.8% vs. 0%, p = 0.05), lower sCD14 levels (mean, 6.23 vs. 6.27 log(10) pg/mL, p = 0.04), lower CD8 T cell counts (mean, 514 vs. 876, p = 0.0003), lower CD4/CD8 T cell ratio (mean, 0.27 vs. 0.41, p = 0.01) and higher expression of PD1 on CD8(+) T cells (74.2% vs. 65.1%, p = 0.02) observed in SIR participants compared to their non-SIR counterparts at year 3 after ART initiation. CONCLUSIONS: Nearly 10% of the study participants who had achieved virological suppression failed to recover a CD4 T cell count > 200 cells/mm(3) after 3 years of ART which was with a very low pre-ART CD4 T cell count and older age. The long-term clinical outcomes of SIR participants need to be further explored. |
format | Online Article Text |
id | pubmed-7646671 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-76466712020-11-27 Characteristics of suboptimal immune response after initiating antiretroviral therapy among people living with HIV with a pre-treatment CD4 T cell count <200 cells/mm(3) in Thailand() Han, Win Min Ubolyam, Sasiwimol Apornpong, Tanakorn Kerr, Stephen J. Hansasuta, Pokrath Gatechompol, Sivaporn Maekanantawat, Wirach Ruxrungtham, Kiat Phanuphak, Praphan Ananworanich, Jintanat Avihingsanon, Anchalee J Virus Erad Original research BACKGROUND: Complete recovery of the CD4 T cell count is uncommon among chronically HIV-infected individuals with very low pre-treatment CD4 count. We studied the prevalence of chronically immune recovery and its associated factors including immune characteristics chronic HIV-infected Thais. METHODS: Treatment-naïve participants (n = 375) from the HIV-NAT 006 cohort with a pre-treatment CD4 T cell count after initiating antiretroviral therapy (ART) and having achieved a suppressed viremia (HIV-RNA level < 400 copies/mL) were retrospectively followed at the Thai Red Cross AIDS Research Centre, Bangkok, Thailand. Suboptimal immune recovery (SIR) was defined as having a CD4(+) T cell count <200 cells/mm(3) for 3 years after ART initiation. A case-control sub-study matched for age, sex and pre-ART CD4 T cell count was conducted to compare immunological characteristics between SIR (n = 17) and non-SIR (n = 24) participants. Immunological biomarkers such as interleukin-7 (IL-7) and soluble CD14 (sCD14) and other covariates including cytomegalovirus (CMV) DNA level, baseline hemoglobin level, hepatitis B and C co-infections, and T cell subsets associated with immune activation and exhaustion were evaluated. RESULTS: Among 375 participants with pre-ART CD4 T cell counts < 200 cells/mm(3), the prevalence of SIR was 39.7%, 19.7% and 7.7% at years 1, 2 and 3 after starting ART, respectively. In a multivariate analysis, a pre-ART CD4 T cell count ≤100 cells/mm(3) (adjusted odds ratio [aOR] 9.45, 95% CI 2.92–30.61, p < 0.001), older age (aOR 1.07, 95% CI 1.01–1.13, p = 0.029) and baseline HIV-RNA level (aOR 0.36, 95% CI 0.21–0.59, p < 0.001) were independently associated with SIR at year 3 after ART initiation. In the matched case-control sub-study (cases = 17, controls = 24), there was a higher prevalence of hepatitis C co-infection (18.8% vs. 0%, p = 0.05), lower sCD14 levels (mean, 6.23 vs. 6.27 log(10) pg/mL, p = 0.04), lower CD8 T cell counts (mean, 514 vs. 876, p = 0.0003), lower CD4/CD8 T cell ratio (mean, 0.27 vs. 0.41, p = 0.01) and higher expression of PD1 on CD8(+) T cells (74.2% vs. 65.1%, p = 0.02) observed in SIR participants compared to their non-SIR counterparts at year 3 after ART initiation. CONCLUSIONS: Nearly 10% of the study participants who had achieved virological suppression failed to recover a CD4 T cell count > 200 cells/mm(3) after 3 years of ART which was with a very low pre-ART CD4 T cell count and older age. The long-term clinical outcomes of SIR participants need to be further explored. Elsevier 2020-07-19 /pmc/articles/PMC7646671/ /pubmed/33251023 http://dx.doi.org/10.1016/j.jve.2020.100005 Text en © 2020 Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original research Han, Win Min Ubolyam, Sasiwimol Apornpong, Tanakorn Kerr, Stephen J. Hansasuta, Pokrath Gatechompol, Sivaporn Maekanantawat, Wirach Ruxrungtham, Kiat Phanuphak, Praphan Ananworanich, Jintanat Avihingsanon, Anchalee Characteristics of suboptimal immune response after initiating antiretroviral therapy among people living with HIV with a pre-treatment CD4 T cell count <200 cells/mm(3) in Thailand() |
title | Characteristics of suboptimal immune response after initiating antiretroviral therapy among people living with HIV with a pre-treatment CD4 T cell count <200 cells/mm(3) in Thailand() |
title_full | Characteristics of suboptimal immune response after initiating antiretroviral therapy among people living with HIV with a pre-treatment CD4 T cell count <200 cells/mm(3) in Thailand() |
title_fullStr | Characteristics of suboptimal immune response after initiating antiretroviral therapy among people living with HIV with a pre-treatment CD4 T cell count <200 cells/mm(3) in Thailand() |
title_full_unstemmed | Characteristics of suboptimal immune response after initiating antiretroviral therapy among people living with HIV with a pre-treatment CD4 T cell count <200 cells/mm(3) in Thailand() |
title_short | Characteristics of suboptimal immune response after initiating antiretroviral therapy among people living with HIV with a pre-treatment CD4 T cell count <200 cells/mm(3) in Thailand() |
title_sort | characteristics of suboptimal immune response after initiating antiretroviral therapy among people living with hiv with a pre-treatment cd4 t cell count <200 cells/mm(3) in thailand() |
topic | Original research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646671/ https://www.ncbi.nlm.nih.gov/pubmed/33251023 http://dx.doi.org/10.1016/j.jve.2020.100005 |
work_keys_str_mv | AT hanwinmin characteristicsofsuboptimalimmuneresponseafterinitiatingantiretroviraltherapyamongpeoplelivingwithhivwithapretreatmentcd4tcellcount200cellsmm3inthailand AT ubolyamsasiwimol characteristicsofsuboptimalimmuneresponseafterinitiatingantiretroviraltherapyamongpeoplelivingwithhivwithapretreatmentcd4tcellcount200cellsmm3inthailand AT apornpongtanakorn characteristicsofsuboptimalimmuneresponseafterinitiatingantiretroviraltherapyamongpeoplelivingwithhivwithapretreatmentcd4tcellcount200cellsmm3inthailand AT kerrstephenj characteristicsofsuboptimalimmuneresponseafterinitiatingantiretroviraltherapyamongpeoplelivingwithhivwithapretreatmentcd4tcellcount200cellsmm3inthailand AT hansasutapokrath characteristicsofsuboptimalimmuneresponseafterinitiatingantiretroviraltherapyamongpeoplelivingwithhivwithapretreatmentcd4tcellcount200cellsmm3inthailand AT gatechompolsivaporn characteristicsofsuboptimalimmuneresponseafterinitiatingantiretroviraltherapyamongpeoplelivingwithhivwithapretreatmentcd4tcellcount200cellsmm3inthailand AT maekanantawatwirach characteristicsofsuboptimalimmuneresponseafterinitiatingantiretroviraltherapyamongpeoplelivingwithhivwithapretreatmentcd4tcellcount200cellsmm3inthailand AT ruxrungthamkiat characteristicsofsuboptimalimmuneresponseafterinitiatingantiretroviraltherapyamongpeoplelivingwithhivwithapretreatmentcd4tcellcount200cellsmm3inthailand AT phanuphakpraphan characteristicsofsuboptimalimmuneresponseafterinitiatingantiretroviraltherapyamongpeoplelivingwithhivwithapretreatmentcd4tcellcount200cellsmm3inthailand AT ananworanichjintanat characteristicsofsuboptimalimmuneresponseafterinitiatingantiretroviraltherapyamongpeoplelivingwithhivwithapretreatmentcd4tcellcount200cellsmm3inthailand AT avihingsanonanchalee characteristicsofsuboptimalimmuneresponseafterinitiatingantiretroviraltherapyamongpeoplelivingwithhivwithapretreatmentcd4tcellcount200cellsmm3inthailand |